Literature DB >> 15908333

Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus.

Xiong Ding1, Chang-You Lu, Ying Mei, Chang-An Liu, Yu-Jun Shi.   

Abstract

BACKGROUND: The incidence of gallstone is higher in patients with diabetes mellitus than in general population because of hypomotility and lowered emptying function. The aim of this study was to investigate the gene expression of cholecystokinin-A (CCK-A) receptor in patients with gallstones and diabetes mellitus and its correlation with the hypomotility of the gallbladder.
METHODS: Smooth muscle was taken from the gallbladder after cholecystectomy and total RNA was extracted from it by Trizol reagent to compose cDNA. CCK-A receptor was enlarged by reverse transcription-polymerase chain reaction (RT-PCR) and identified by electrophoresis. Based on the analysis of images, the relative expression of the CCK-A receptor was obtained after comparison of the CCK-A receptor and beta-action. The emptying function of the gallbladder was measured with B ultrasound before operation.
RESULTS: Gallbladder ejection fraction (GBEF2) (%) (24.9+/-12.7) decreased more significantly in patients with gallstones and diabetes mellitus than in those with simple gallstone (61.5+/-8.5) (P<0.01). In the two groups, a fraction of 540bp of CCK-A receptor could be testified respectively, but the relative expression was different. Compared to the expression of beta-action, it was 0.400+/-0.068 in patients with gallstones and diabetes mellitus, but 0.622+/-0.070 in those with gallstone only (F=7.169, Pu0.01). The result was consistent with the decreased contractility.
CONCLUSIONS: The gene expression of CCK-A receptor on the smooth muscle of the gallbladder may decrease more significantly in patients with gallstone and diabetes mellitus than in those with gallstone only; this result is consistent with the decreased motility. Thus the lowered expression of CCK-A receptor is probably the cause of hypomotility in patients with gallstones and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908333

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  9 in total

Review 1.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

2.  Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.

Authors:  Feriel Sellam; Noria Harir; Méghit B Khaled; Nesrine M Mrabent; Rachida Salah; Mustapha Diaf
Journal:  J Gastrointest Cancer       Date:  2015-06

3.  A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.

Authors:  Sobha Puppala; Gerald D Dodd; Sharon Fowler; Rector Arya; Jennifer Schneider; Vidya S Farook; Richard Granato; Thomas D Dyer; Laura Almasy; Christopher P Jenkinson; Andrew K Diehl; Michael P Stern; John Blangero; Ravindranath Duggirala
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

4.  Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.

Authors:  Stephanie E Woods; Monika R Leonard; Joshua A Hayden; Megan Brunjes Brophy; Kara R Bernert; Brigitte Lavoie; Sureshkumar Muthupalani; Mark T Whary; Gary M Mawe; Elizabeth M Nolan; Martin C Carey; James G Fox
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

Review 5.  Biliary dyskinesia in pediatrics.

Authors:  Grzegorz Telega
Journal:  Curr Gastroenterol Rep       Date:  2006-04

6.  Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  Hong-Li Xu; Ann W Hsing; Emily Vogtmann; Lisa W Chu; Jia-Rong Cheng; Jing Gao; Yu-Ting Tan; Bing-Sheng Wang; Ming-Chang Shen; Yu-Tang Gao
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

Review 7.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 8.  A Practical Approach to Gastrointestinal Complications of Diabetes.

Authors:  Abigail Maisey
Journal:  Diabetes Ther       Date:  2016-07-18       Impact factor: 2.945

9.  ATP binding cassette and cholecystokinin A receptor genetic variations in gallstone susceptibility.

Authors:  Saman Milanizadeh; Seyed Reza Mohebbi; Mahsa Khanyaghma; Amir Houshang Mohammad Alizadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.